Determinants of survival following HIV-1 seroconversion after the introduction of HAART. (Q33973379)

30 July 2017

title

Determinants of survival following HIV-1 seroconversion after the introduction of HAART. (English)

1 reference

30 July 2017

1 reference

3

Krishnan Bhaskaran

1 reference

30 July 2017

7

A Sarah Walker

1 reference

30 July 2017

Kholoud Porter

1

1 reference

30 July 2017

Abdel Babiker

2

1 reference

30 July 2017

Janet Darbyshire

4

1 reference

30 July 2017

Patrizio Pezzotti

5

1 reference

30 July 2017

Kholoud Porter

6

1 reference

30 July 2017

CASCADE Collaboration

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

30 July 2017

1 reference

30 July 2017

volume

362

1 reference

30 July 2017

issue

9392

1 reference

30 July 2017

page(s)

1267-1274

1 reference

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

The prevalent cohort study and the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Effect of ignoring the time of HIV seroconversion in estimating changes in survival over calendar time in observational studies: results from CASCADE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

The practical significance of potential biases in estimates of the AIDS incubation period distribution _in the UK Register of HIV Seroconverters

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Barriers to use of free antiretroviral therapy in injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Changes in the human thymus during aging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Clinical, Biologic, and Behavioral Predictors of Early Immunologic and Virologic Response in HIV-Infected Patients Initiating Protease Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Therapy naivete in the era of potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914570-9

7 January 2021

10.1016/S0140-6736(03)14570-9

Identifiers

DOI

1 reference

30 July 2017

1 reference